All News #Library
Biotech
Zambon Announce First patient dosed in Ph 3b ADIP study of IPX203
22 Dec 2025 //
PRESS RELEASE
Amneal Enters into European Licensing Agreement with Zambon Biotech for IPX203
27 Feb 2024 //
PRESS RELEASE

Market Place
Sourcing Support